Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories-Reference-Cited by-同舟云学术

Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories

Published:2020-07-23 Issue:8 Volume:58 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Lieberman Joshua A.¹,Pepper Gregory¹,Naccache Samia N.²,Huang Meei-Li¹³,Jerome Keith R.¹³,Greninger Alexander L.¹³

Affiliation:

1. Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA

2. LabCorp Seattle, Department of Microbiology, Seattle, Washington, USA

3. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

Abstract

Multiple laboratory-developed tests (LDTs) and commercially available assays have emerged to meet diagnostic needs related to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To date, there is limited comparison data for these different testing platforms. We compared the analytical performance of a LDT developed in our clinical laboratory based on CDC primer sets and four commercially available, FDA emergency use authorized assays for SARS-CoV-2 (Cepheid, DiaSorin, Hologic Panther, and Roche Cobas) on a total of 169 nasopharyngeal swabs.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.00821-20

Reference8 articles.

1. First Case of 2019 Novel Coronavirus in the United States

2. IHME COVID-19 health service utilization forecasting team Murray CJL. 30 March 2020. Forecasting COVID-19 impact on hospital bed-days ICU-days ventilator-days and deaths by US state in the next 4 months. medRxiv doi:10.1101/2020.03.27.20043752.

3. An interactive web-based dashboard to track COVID-19 in real time

4. SARS-CoV-2 Testing

5. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IVDCheckR – simplifying documentation for laboratory developed tests according to IVDR requirements by introducing a new digital tool;Clinical Chemistry and Laboratory Medicine (CCLM);2024-08-26

2. SARS-CoV-2 Polymerase Chain Reaction Cycle Threshold Trends in Patients Who Are Immunocompromised and Implications for Isolation Precautions;Open Forum Infectious Diseases;2024-06-28

3. The Effect of Gastrointestinal Graft-Versus-Host Disease and Diarrhea on the Pharmacokinetic Profile of Sotrovimab in Hematopoietic Stem Cell Transplant Recipients;The Journal of Infectious Diseases;2024-05-14

4. Rendimiento diagnóstico de un sistema molecularde uso en el punto de atención para la detección de SARS-CoV-2 en Perú;Revista Peruana de Medicina Experimental y Salud Pública;2024-05-08

5. Lung Donor Selection and Management: An Updated Review;OBM Transplantation;2023-11-23